FDA to Patients: Transvaginal Mesh Complications Not Rare
On multiple occasions, the Food and Drug Administration has clearly communicated its finding that transvaginal mesh complications are not rare. According to the FDA, these complications are serious and that the risks associated with invasive surgical procedures may not be worth the risk. In particular, the FDA has found that newer, surgical options are not necessarily more effective than traditional options, despite the added risk.
Have you had a POP or SUI surgery involving a transvaginal mesh device? Whether you’ve experienced post-surgical symptoms at this point or not, you should probably talk to the experts at Fears Nachawati. With years of experience and dedicated expertise, we know how to advise you about your legal rights and help you determine whether you’ve suffered harm at the hands of a medical device manufacturer. For your free consultation, call us at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!